Page 11 - Read Online
P. 11
68 Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus
Cecilia Monge Bonilla, Nicole A. McGrath, Jianyang Fu, Changqing Xie
Hepatoma Res 2020;6:68 http://dx.doi.org/10.20517/2394-5079.2020.58
69 Beneficial effects of coffee in non-alcoholic fatty liver disease: a narrative review
Alessio Calabrò, Anna Caterina Procopio, Francesco Primerano, Tiziana Larussa, Francesco Luzza, Laura Di
Renzo, Antonino De Lorenzo, Paola Gualtieri, Ludovico Abenavoli
Hepatoma Res 2020;6:69 http://dx.doi.org/10.20517/2394-5079.2020.63
70 Systemic therapy for advanced cholangiocarcinoma: new options on the horizon
Saleh A. Alqahtani, Massimo Colomboa
Hepatoma Res 2020;6:70 http://dx.doi.org/10.20517/2394-5079.2020.65
71 Post liver transplant recurrence in patients with hepatocellular carcinoma: not necessarily the end of the
road!
Prashant Bhangui, Sanjay Yadav, AS Soin
Hepatoma Res 2020;6:71 http://dx.doi.org/10.20517/2394-5079.2020.67
72 The transcontinental variability of nonalcoholic fatty liver disease
Claudia P. Oliveira, Angelo Paredes, Mohammed Siddiqui, Lawrence Serfaty, Abhijit Chowdhury, Jose Tadeu
Stefano, Denise Siqueira Vanni, Sherry Boyett, Arun J. Sanyal
Hepatoma Res 2020;6:72 http://dx.doi.org/10.20517/2394-5079.2020.73
73 Cutaneous toxicities of targeted therapies in the treatment of hepatocellular carcinoma
Tarik Silk, Jennifer Wu
Hepatoma Res 2020;6:73 http://dx.doi.org/10.20517/2394-5079.2020.61
74 The role of genetic factors in HBV-related HCC: perspectives from local genetic backgrounds and clinical
epidemiology
Dar-In Tai, Jennifer Tai
Hepatoma Res 2020;6:74 http://dx.doi.org/10.20517/2394-5079.2020.54
75 Should selection criteria for HCC be the same (or different) between LDLT and DDLT?
Flavia Feier
Hepatoma Res 2020;6:75 http://dx.doi.org/10.20517/2394-5079.2020.68
76 Living donor liver transplantation for patients with advanced hepatocellular carcinoma
J. Michael Cullen, Paola Vargas, Nicolas Goldaracena
Hepatoma Res 2020;6:76 http://dx.doi.org/10.20517/2394-5079.2020.69
77 Advances in minimally invasive surgery for hepatocellular carcinoma
Cun-Zhen Zhang, Nan Li
Hepatoma Res 2020;6:77 http://dx.doi.org/10.20517/2394-5079.2020.74
